{
 "as_of": "2026-11-08",
 "cmr": "us-cm-kg/NASDAQ/CAPR",
 "fence": "The page is the record's research on the issuer — no analyst, no rating, no view.",
 "markdown": "The page is the record's research on the issuer — no analyst, no rating, no view.\n\n# CAPRICOR THERAPEUTICS, INC. (NASDAQ: CAPR) — research page\n\nAs of 2026-11-08 · us-cm-kg · record version 1\n\n## Identity and listing\n\nThe issuer is CAPRICOR THERAPEUTICS, INC., listed on NASDAQ under ticker CAPR, with ISIN US14070B3096 and LEI 5493002ZI5PDLXV4DX14. Its security type is Corporate, its segment is not on the record, its sector is 2834 Pharmaceutical Preparations, and its jurisdiction is United States, Delaware. Its listing status is listed, not halted.\n\n## The disclosure read\n\nThe record holds 67 filings in the twelve months to 2026-11-08, on 41 filing days. The median gap between filing days is 5.0 days, against a NASDAQ median of 6.0 days and a 2834 Pharmaceutical Preparations median of 6.0 days. The latest filing is a regulatory filing dated 2026-10-14, 25 days before the record date, against a NASDAQ median latency of 5.0 days and a sector median of 4.0 days. The filings comprise 26 directors' dealings, 17 regulatory filings, 10 corporate news, 8 results, 3 prospectuses and 3 AGM/EGM notices.\n\n## Auditor\n\nThe auditor of record is Rose, Snyder & Jacobs LLP, located in Encino, California. The record holds no auditor changes.\n\n## Events and halts\n\nThe record holds no listing, delisting or name change lines. The domicile change is not on the record, because EDGAR states no dated change of state of incorporation on a filing line. The segment move is not on the record, because the exchanges' tier transfers are not EDGAR filings. The halt flag reads listed, not halted.\n\n## Orderability\n\nThe outcome is not determinable, because the chapter's orderability section carries no client categories and so the outcome cannot name its client category. The rule version is acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, and the chapter is as of 2026-11-04.\n\n## Coverage\n\nThe issuer's investor-relations page names 10 research houses: B. Riley Securities, Oppenheimer & Co. Inc., Ladenburg Thalmann & Co. Inc., Cantor Fitzgerald & Co., Maxim Group, JonesTrading, ROTH Capital Partners, H.C. Wainwright & Co., Piper Sandler & Co., and A.G.P. / Alliance Global Partners.\n\n## Open research\n\nNo openly published research notes were found on the record.\n\n## Licensed\n\nLicensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.\n\n## As-of depth\n\nThe record holds sealed years 2021, 2022, 2023, 2024, 2025 and 2026 for the issuer. The market's earliest sealed date is 2021-01-04, and the live record began on 2026-09-12. The market's vintage is sealed.\n\n## Sources\n\n10 source pages are named on this page; every value above carries its own source page and read date in the numbers.\n\n- https://www.sec.gov/files/company_tickers_exchange.json (identity.exchange)\n- https://mapping.gleif.org/api/v2/isin-lei/latest (identity.isin)\n- https://data.sec.gov/submissions/CIK0001133869.json (identity.jurisdiction)\n- https://mapping.gleif.org/api/v2/isin-lei/latest/download (identity.lei)\n- https://mcp.us-cm-kg.ai/events/NASDAQ/CAPR (the disclosure lines)\n- https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts (the halt flag)\n- https://www.sec.gov/Archives/edgar/data/1133869/000110465926029580/capr-20251231x10k.htm (the auditor)\n- https://mcp.us-cm-kg.ai/book/aio.json (the orderability chapter)\n- https://www.capricor.com/investors/stock-data/analyst-coverage (coverage)\n- https://mcp.us-cm-kg.ai/record/NASDAQ/CAPR (the record)\n",
 "market": "US",
 "node": "us-cm-kg",
 "numbers": {
  "as_of_depth": {
   "issuer_years_sealed": [
    "2021",
    "2022",
    "2023",
    "2024",
    "2025",
    "2026"
   ],
   "live_record_began": "2026-09-12",
   "node_history_from": "2021-01-04",
   "node_years_sealed": [
    "2021",
    "2022",
    "2023",
    "2024",
    "2025",
    "2026"
   ],
   "record_version": 1,
   "sealed": true
  },
  "auditor": {
   "auditor": {
    "read_by": "EDGAR 10-K cover page iXBRL tag (dei:AuditorName, dei:AuditorLocation, dei:AuditorFirmId, dei:DocumentPeriodEndDate)",
    "read_date": "2026-11-08",
    "read_date_basis": "the record version as_of",
    "source": "https://www.sec.gov/Archives/edgar/data/1133869/000110465926029580/capr-20251231x10k.htm",
    "state": "sourced",
    "value": "Rose, Snyder & Jacobs LLP"
   },
   "auditor_firm_id": {
    "read_by": "EDGAR 10-K cover page iXBRL tag (dei:AuditorName, dei:AuditorLocation, dei:AuditorFirmId, dei:DocumentPeriodEndDate)",
    "read_date": "2026-11-08",
    "read_date_basis": "the record version as_of",
    "source": "https://www.sec.gov/Archives/edgar/data/1133869/000110465926029580/capr-20251231x10k.htm",
    "state": "sourced",
    "value": "468"
   },
   "auditor_location": {
    "read_by": "EDGAR 10-K cover page iXBRL tag (dei:AuditorName, dei:AuditorLocation, dei:AuditorFirmId, dei:DocumentPeriodEndDate)",
    "read_date": "2026-11-08",
    "read_date_basis": "the record version as_of",
    "source": "https://www.sec.gov/Archives/edgar/data/1133869/000110465926029580/capr-20251231x10k.htm",
    "state": "sourced",
    "value": "Encino, California"
   },
   "changes": []
  },
  "cmr": "us-cm-kg/NASDAQ/CAPR",
  "coverage": {
   "count": 10,
   "houses": [
    {
     "analyst": "Madison El-Saadi, Ph.D.",
     "house": "B. Riley Securities",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-11",
     "source": "https://www.capricor.com/investors/stock-data/analyst-coverage",
     "state": "sourced"
    },
    {
     "analyst": "Leland Gershell, M.D., Ph.D.",
     "house": "Oppenheimer & Co. Inc.",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-11",
     "source": "https://www.capricor.com/investors/stock-data/analyst-coverage",
     "state": "sourced"
    },
    {
     "analyst": "Rick Bienkowski, Ph.D.",
     "house": "Ladenburg Thalmann & Co. Inc.",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-11",
     "source": "https://www.capricor.com/investors/stock-data/analyst-coverage",
     "state": "sourced"
    },
    {
     "analyst": "Kristen Kluska",
     "house": "Cantor Fitzgerald & Co.",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-11",
     "source": "https://www.capricor.com/investors/stock-data/analyst-coverage",
     "state": "sourced"
    },
    {
     "analyst": "Jason McCarthy, Ph.D.",
     "house": "Maxim Group",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-11",
     "source": "https://www.capricor.com/investors/stock-data/analyst-coverage",
     "state": "sourced"
    },
    {
     "analyst": "Catherine Novack",
     "house": "JonesTrading",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-11",
     "source": "https://www.capricor.com/investors/stock-data/analyst-coverage",
     "state": "sourced"
    },
    {
     "analyst": "Boobalan Pachaiyappan, Ph.D.",
     "house": "ROTH Capital Partners",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-11",
     "source": "https://www.capricor.com/investors/stock-data/analyst-coverage",
     "state": "sourced"
    },
    {
     "analyst": "Joseph Pantginis, Ph.D.",
     "house": "H.C. Wainwright & Co.",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-11",
     "source": "https://www.capricor.com/investors/stock-data/analyst-coverage",
     "state": "sourced"
    },
    {
     "analyst": "Edward A. Tenthoff",
     "house": "Piper Sandler & Co.",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-11",
     "source": "https://www.capricor.com/investors/stock-data/analyst-coverage",
     "state": "sourced"
    },
    {
     "analyst": "Matthew Venezia",
     "house": "A.G.P. / Alliance Global Partners",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-11",
     "source": "https://www.capricor.com/investors/stock-data/analyst-coverage",
     "state": "sourced"
    }
   ],
   "pages_checked": [
    {
     "page": "https://www.capricor.com/investors/stock-data/analyst-coverage",
     "result": "read: 10 of 20 named houses found on the page"
    }
   ],
   "read_by": "Perplexity sonar (search) · page read by this rail",
   "read_date": "2026-11-11",
   "since": "not stated on the page read",
   "state": "found"
  },
  "disclosure": {
   "against": {
    "exchange": {
     "issuers": 4359,
     "median_cadence_gap_days": 6,
     "median_filings": 52,
     "median_latency_days": 5,
     "name": "NASDAQ"
    },
    "sector": {
     "issuers": 526,
     "median_cadence_gap_days": 6,
     "median_filings": 63,
     "median_latency_days": 4,
     "name": "2834 Pharmaceutical Preparations"
    }
   },
   "by_type": {
    "agm_egm": 3,
    "corporate_news": 10,
    "directors_dealings": 26,
    "prospectus": 3,
    "regulatory_filing": 17,
    "results": 8
   },
   "cadence_median_gap_days": 5,
   "filing_days": 41,
   "filings": 67,
   "latency_days": 25,
   "latest": [
    {
     "category": "SCHEDULE 13G/A",
     "date": "2026-10-14",
     "source": "https://www.sec.gov/Archives/edgar/data/1133869/000110465926115876/xslSCHEDULE_13G_X02/primary_doc.xml",
     "title": "SCHEDULE 13G/A",
     "type": "regulatory_filing"
    },
    {
     "category": "SCHEDULE 13G",
     "date": "2026-09-14",
     "source": "https://www.sec.gov/Archives/edgar/data/1133869/000110465926107591/xslSCHEDULE_13G_X02/primary_doc.xml",
     "title": "SCHEDULE 13G",
     "type": "regulatory_filing"
    },
    {
     "category": "8-K",
     "date": "2026-08-24",
     "source": "https://www.sec.gov/Archives/edgar/data/1133869/000110465926100071/capr-20260824x8k.htm",
     "title": "8-K — 8-K (items 8.01,9.01)",
     "type": "corporate_news"
    },
    {
     "category": "SCHEDULE 13G",
     "date": "2026-08-19",
     "source": "https://www.sec.gov/Archives/edgar/data/1133869/000110465926098872/xslSCHEDULE_13G_X02/primary_doc.xml",
     "title": "SCHEDULE 13G",
     "type": "regulatory_filing"
    },
    {
     "category": "SCHEDULE 13G/A",
     "date": "2026-08-14",
     "source": "https://www.sec.gov/Archives/edgar/data/1133869/000121465926010417/xslSCHEDULE_13G_X02/primary_doc.xml",
     "title": "SCHEDULE 13G/A",
     "type": "regulatory_filing"
    }
   ],
   "latest_filing_date": "2026-10-14",
   "read": "the node's event lines (list_events_since), as get_filings serves them",
   "source": "https://mcp.us-cm-kg.ai/events/NASDAQ/CAPR",
   "window": {
    "from": "2025-11-08",
    "to": "2026-11-08"
   }
  },
  "identity": {
   "exchange": {
    "read_by": "EDGAR company_tickers_exchange.json (SEC list of exchange-listed filers)",
    "read_date": "2026-11-08",
    "read_date_basis": "the record version as_of",
    "source": "https://www.sec.gov/files/company_tickers_exchange.json",
    "state": "sourced",
    "value": "NASDAQ"
   },
   "isin": {
    "read_by": "GLEIF ISIN-to-LEI mapping file (ISINs mapped to the LEI)",
    "read_date": "2026-11-08",
    "read_date_basis": "the record version as_of",
    "source": "https://mapping.gleif.org/api/v2/isin-lei/latest",
    "state": "sourced",
    "value": "US14070B3096"
   },
   "jurisdiction": {
    "read_by": "EDGAR submissions API (issuer header as filed) (stateOfIncorporation)",
    "read_date": "2026-11-08",
    "read_date_basis": "the record version as_of",
    "source": "https://data.sec.gov/submissions/CIK0001133869.json",
    "state": "sourced",
    "value": "United States — Delaware"
   },
   "lei": {
    "read_by": "GLEIF ISIN-to-LEI mapping file (daily), LEI by exact ISIN",
    "read_date": "2026-11-08",
    "read_date_basis": "the field",
    "source": "https://mapping.gleif.org/api/v2/isin-lei/latest/download (ISIN US14070B3096)",
    "state": "sourced",
    "value": "5493002ZI5PDLXV4DX14"
   },
   "name": {
    "read_by": "EDGAR submissions API (issuer header as filed)",
    "read_date": "2026-11-08",
    "read_date_basis": "the record version as_of",
    "source": "https://data.sec.gov/submissions/CIK0001133869.json",
    "state": "sourced",
    "value": "CAPRICOR THERAPEUTICS, INC."
   },
   "sector": {
    "read_by": "EDGAR submissions API (issuer header as filed) (SIC code as assigned by the SEC)",
    "read_date": "2026-11-08",
    "read_date_basis": "the record version as_of",
    "source": "https://data.sec.gov/submissions/CIK0001133869.json",
    "state": "sourced",
    "value": "2834 Pharmaceutical Preparations"
   },
   "security_type": {
    "read_by": "EDGAR submissions API (issuer header as filed)",
    "read_date": "2026-11-08",
    "read_date_basis": "the record version as_of",
    "source": "https://data.sec.gov/submissions/CIK0001133869.json",
    "state": "sourced",
    "value": "Corporate"
   },
   "segment": {
    "market": "US",
    "state": "not_on_record"
   },
   "ticker": {
    "read_by": "EDGAR company_tickers_exchange.json (SEC list of exchange-listed filers)",
    "read_date": "2026-11-08",
    "read_date_basis": "the record version as_of",
    "source": "https://www.sec.gov/files/company_tickers_exchange.json",
    "state": "sourced",
    "value": "CAPR"
   },
   "website": {
    "market": "US",
    "state": "not_on_record"
   }
  },
  "licensed": {
   "columns": [
    "licensor",
    "entitlement",
    "title",
    "date",
    "source"
   ],
   "rows": [],
   "rule": "A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded."
  },
  "lifecycle": {
   "delisting": [],
   "domicile_change": {
    "market": "US",
    "reason": "EDGAR states no dated change of state of incorporation on a filing line",
    "state": "not_on_record"
   },
   "listing": [],
   "name_change": [],
   "segment_move": {
    "market": "US",
    "reason": "the exchanges' tier transfers are not EDGAR filings",
    "state": "not_on_record"
   }
  },
  "market": "US",
  "node": "us-cm-kg",
  "numbers_hash": "sha256:d8a5ccc27d7ce62f6ea3e05d275b4b3ec830946643238869c08eaeaf88cf1335",
  "open_research": {
   "read_date": "2026-11-11",
   "rows": [],
   "state": "none_found"
  },
  "orderability": {
   "chapter_as_of": "2026-11-04",
   "client_categories": [],
   "determinable": false,
   "read": {
    "chapter": "https://mcp.us-cm-kg.ai/book/aio.json",
    "door": "https://mcp.us-cm-kg.ai/mcp",
    "tool": "get_orderability"
   },
   "reason": "the chapter's orderability section carries no client_categories: the outcome cannot name its client category",
   "rule_version": "acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1",
   "section": "us.aio.v8"
  },
  "record": {
   "as_of": "2026-11-08",
   "url": "https://mcp.us-cm-kg.ai/record/NASDAQ/CAPR",
   "version": 1
  },
  "schema": "research-numbers v0.1 (USR-01, 2026-11-11)",
  "status": {
   "read_date": "2026-11-08",
   "source": "https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts",
   "value": "listed, not halted"
  }
 },
 "numbers_hash": "sha256:d8a5ccc27d7ce62f6ea3e05d275b4b3ec830946643238869c08eaeaf88cf1335",
 "path": "/us/NASDAQ/CAPR",
 "schema": "research-page v0.1 (USR-02, 2026-11-11)",
 "sections": [
  {
   "id": "identity",
   "text": "The issuer is CAPRICOR THERAPEUTICS, INC., listed on NASDAQ under ticker CAPR, with ISIN US14070B3096 and LEI 5493002ZI5PDLXV4DX14. Its security type is Corporate, its segment is not on the record, its sector is 2834 Pharmaceutical Preparations, and its jurisdiction is United States, Delaware. Its listing status is listed, not halted.",
   "title": "Identity and listing"
  },
  {
   "id": "disclosure",
   "text": "The record holds 67 filings in the twelve months to 2026-11-08, on 41 filing days. The median gap between filing days is 5.0 days, against a NASDAQ median of 6.0 days and a 2834 Pharmaceutical Preparations median of 6.0 days. The latest filing is a regulatory filing dated 2026-10-14, 25 days before the record date, against a NASDAQ median latency of 5.0 days and a sector median of 4.0 days. The filings comprise 26 directors' dealings, 17 regulatory filings, 10 corporate news, 8 results, 3 prospectuses and 3 AGM/EGM notices.",
   "title": "The disclosure read"
  },
  {
   "id": "auditor",
   "text": "The auditor of record is Rose, Snyder & Jacobs LLP, located in Encino, California. The record holds no auditor changes.",
   "title": "Auditor"
  },
  {
   "id": "events",
   "text": "The record holds no listing, delisting or name change lines. The domicile change is not on the record, because EDGAR states no dated change of state of incorporation on a filing line. The segment move is not on the record, because the exchanges' tier transfers are not EDGAR filings. The halt flag reads listed, not halted.",
   "title": "Events and halts"
  },
  {
   "id": "orderability",
   "text": "The outcome is not determinable, because the chapter's orderability section carries no client categories and so the outcome cannot name its client category. The rule version is acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, and the chapter is as of 2026-11-04.",
   "title": "Orderability"
  },
  {
   "id": "coverage",
   "text": "The issuer's investor-relations page names 10 research houses: B. Riley Securities, Oppenheimer & Co. Inc., Ladenburg Thalmann & Co. Inc., Cantor Fitzgerald & Co., Maxim Group, JonesTrading, ROTH Capital Partners, H.C. Wainwright & Co., Piper Sandler & Co., and A.G.P. / Alliance Global Partners.",
   "title": "Coverage"
  },
  {
   "id": "open_research",
   "text": "No openly published research notes were found on the record.",
   "title": "Open research"
  },
  {
   "id": "licensed",
   "text": "Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.",
   "title": "Licensed"
  },
  {
   "id": "depth",
   "text": "The record holds sealed years 2021, 2022, 2023, 2024, 2025 and 2026 for the issuer. The market's earliest sealed date is 2021-01-04, and the live record began on 2026-09-12. The market's vintage is sealed.",
   "title": "As-of depth"
  },
  {
   "id": "sources",
   "text": "10 source pages are named on this page; every value above carries its own source page and read date in the numbers.",
   "title": "Sources"
  }
 ],
 "sources": [
  {
   "for": "identity.exchange",
   "source": "https://www.sec.gov/files/company_tickers_exchange.json"
  },
  {
   "for": "identity.isin",
   "source": "https://mapping.gleif.org/api/v2/isin-lei/latest"
  },
  {
   "for": "identity.jurisdiction",
   "source": "https://data.sec.gov/submissions/CIK0001133869.json"
  },
  {
   "for": "identity.lei",
   "source": "https://mapping.gleif.org/api/v2/isin-lei/latest/download"
  },
  {
   "for": "the disclosure lines",
   "source": "https://mcp.us-cm-kg.ai/events/NASDAQ/CAPR"
  },
  {
   "for": "the halt flag",
   "source": "https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts"
  },
  {
   "for": "the auditor",
   "source": "https://www.sec.gov/Archives/edgar/data/1133869/000110465926029580/capr-20251231x10k.htm"
  },
  {
   "for": "the orderability chapter",
   "source": "https://mcp.us-cm-kg.ai/book/aio.json"
  },
  {
   "for": "coverage",
   "source": "https://www.capricor.com/investors/stock-data/analyst-coverage"
  },
  {
   "for": "the record",
   "source": "https://mcp.us-cm-kg.ai/record/NASDAQ/CAPR"
  }
 ],
 "title": "CAPRICOR THERAPEUTICS, INC. (CAPR) — research page",
 "writer": {
  "by": "Claude through the platform account, Haiku class; one pass; checked against the numbers",
  "engine": "claude-haiku-5-5"
 }
}